AQST
Aquestive Therapeutics, Inc. - Common Stock (AQST)
$78
About Aquestive Therapeutics, Inc. - Common Stock (AQST)
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Details
Daily high
$4.82
Daily low
$4.56
Price at open
$4.65
52 Week High
$7.55
52 Week Low
$2.93
Market cap
578.6M
Dividend yield
-
Volume
2.5M
Avg. volume
2.6M
P/E ratio
-7.10
Aquestive Therapeutics, Inc. - Common Stock News
Details
Daily high
$4.82
Daily low
$4.56
Price at open
$4.65
52 Week High
$7.55
52 Week Low
$2.93
Market cap
578.6M
Dividend yield
-
Volume
2.5M
Avg. volume
2.6M
P/E ratio
-7.10